Analyst Consensus ?
ConsensusHold29 ratings
Bullish1551.7%
Neutral1344.8%
Bearish13.5%
Tyson Foods, Inc. · TSN · FY2026 Q3 · Calendar Q3 2026
Tyson: Chicken and Prepared Foods lead, Beef remains the drag
The current analysis supports a mixed operating picture: resilient demand and innovation are helping Chicken and Prepared Foods, but Beef losses and commodity exposure remain meaningful offsets. The evidence is constructive for operational progress, not conclusive on a broad earnings-growth trajectory.
Reported Before market openNYSEConsumer Defensive
$18.37B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.99
Consensus $0.99
EPS surprise
+0.1%
Reported versus consensus
Reported revenue
$13.87B
Consensus $14.07B
Revenue surprise
-1.4%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+2.8%
Event window
SPY move
+1.4%
Same window
Abnormal move
+1.4%
Stock minus SPY
Volume
1.9×
Versus trailing sessions
Subsequent drift
-7.5%
Up to 20 sessions
TSNSPY benchmark
Ask FN2 about TSN FY2026 Q3
Transcript, numbers and history already loaded
Why did TSN rise 2.8% after beating EPS estimates in FY2026 Q3?What changed in TSN's guidance and outlook in FY2026 Q3?Give me the bull and bear case for TSN after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, the overall outlook was maintained rather than raised broadly. Prepared Foods guidance improved, Beef loss guidance was lowered, and management added detail on Mexican cattle-border reopening, the Chicken genetics rollout, and Agentic AI product testing.
Guidance delta
Management maintained the overall FY2026 outlook, raised the Prepared Foods operating-income midpoint, reaffirmed Chicken, Pork, and International outlooks, and lowered the expected Beef loss.
Key takeaways
- Prepared Foods and Chicken were the main operating bright spots, with volume and share gains across key brands.
- Beef remained challenged by cattle supply constraints and margin pressure, while a phased reopening of the Mexican cattle border was identified as a potential long-term tailwind.
- Management is extending value-added product innovation, digital engagement, genetics improvements, and operational efficiency efforts.
Management priorities
- Expand value-added offerings, including Hillshire Reserve and the Jimmy Dean high-protein platform.
- Continue improving Chicken genetics and live-performance yields.
- Advance AI-enabled product development, footprint optimization, and automation.
Follow TSN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$51.82Current
$35Low
$63.5Average
$99High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 23, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Neutral | Upgrade | Sep 18, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Sep 10, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 4, 2026 |
| Barclays | Overweight | Overweight | Maintain | Sep 4, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Jul 2, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 2, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | May 5, 2026 |
| Mizuho | Outperform | Buy | Maintain | Mar 26, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Apr 15, 2025 |
| HSBC | Reduce | Reduce | Maintain | May 7, 2024 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 17, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 7, 2023 |
| Argus Research | Hold | Buy | Downgrade | Sep 13, 2022 |
| Buckingham Research | Neutral | Neutral | Maintain | Feb 20, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Feb 20, 2020 |
| Bank of America | Buy | Buy | Maintain | Nov 13, 2019 |
| Argus | Buy | Hold | Upgrade | May 14, 2019 |
| Vertical Research | Buy | Hold | Upgrade | Jan 10, 2019 |
| Vertical Group | Buy | Hold | Upgrade | Jan 10, 2019 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 8, 2018 |
| Pivotal Research | Hold | Sell | Upgrade | Nov 13, 2017 |
| Jefferies | Buy | Buy | Maintain | Oct 30, 2017 |
| CLSA | Buy | Outperform | Maintain | Oct 10, 2016 |
| BB&T Capital | Hold | Buy | Downgrade | Mar 4, 2016 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Jan 5, 2016 |
| Cleveland Research | Buy | Neutral | Upgrade | Feb 5, 2015 |
| KeyBanc | Buy | Buy | Maintain | Jul 29, 2014 |
| DA Davidson | Buy | Buy | Maintain | Jul 10, 2013 |
| Miller Tabak | Buy | Neutral | Upgrade | May 7, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $51.82. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $66 | $51.74 | +27.4% | Sep 10, 2026 |
| Barclays | Analyst unavailable | $75 | $51.76 | +44.7% | Sep 4, 2026 |
| BMO Capital | Andrew Strelzik | $65 | $51.76 | +25.4% | Sep 4, 2026 |
| Bernstein | Alexia Howard | $66 | $58.12 | +27.4% | Aug 4, 2026 |
| Coker Palmer | Thomas Palmer | $65 | $57.48 | +25.4% | Jul 14, 2026 |
| Bernstein | Analyst unavailable | $63 | $58.43 | +21.6% | Jul 2, 2026 |
| Piper Sandler | Michael Lavery | $78 | $56.2 | +50.5% | Jun 18, 2026 |
| Piper Sandler | Analyst unavailable | $80 | $68.76 | +54.4% | May 4, 2026 |
| Bernstein | Analyst unavailable | $69 | $65.74 | +33.2% | Feb 3, 2026 |
| BMO Capital | Andrew Strelzik | $73 | $65.74 | +40.9% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $78 | $65.74 | +50.5% | Feb 3, 2026 |
| BMO Capital | Analyst unavailable | $67 | $56.2 | +29.3% | Jan 8, 2026 |
| Piper Sandler | Michael Lavery | $61 | $59.56 | +17.7% | Dec 12, 2025 |
| Stephens | Pooran Sharma | $61 | $55.75 | +17.7% | May 6, 2025 |
| Coker Palmer | Thomas Palmer | $60 | $60.54 | +15.8% | Apr 15, 2025 |
| Piper Sandler | Michael Lavery | $58 | $61.69 | +11.9% | Nov 13, 2024 |
| BMO Capital | Andrew Strelzik | $62 | $61.69 | +19.6% | Nov 13, 2024 |
| Barclays | Benjamin Theuer | $76 | $62.66 | +46.7% | Nov 12, 2024 |
| Bank of America Securities | Peter Galbo | $62 | $59.85 | +19.6% | Oct 15, 2024 |
| Piper Sandler | Michael Lavery | $50 | $60.52 | -3.5% | Sep 25, 2024 |
| Barclays | Benjamin Theuer | $72 | $65.13 | +38.9% | Sep 5, 2024 |
| BMO Capital | Andrew Strelzik | $60 | $62.08 | +15.8% | Aug 6, 2024 |
| Coker Palmer | Thomas Palmer | $63 | $62.51 | +21.6% | Aug 5, 2024 |
| Piper Sandler | Michael Lavery | $57 | $58.33 | +10.0% | May 7, 2024 |
| BMO Capital | Andrew Strelzik | $58 | $58.28 | +11.9% | May 7, 2024 |
| Barclays | Benjamin Theuer | $69 | $58.12 | +33.2% | Apr 16, 2024 |
| Coker Palmer | Thomas Palmer | $62 | $57.6 | +19.6% | Apr 3, 2024 |
| Loop Capital Markets | Andrew Strelzik | $46 | $47.77 | -11.2% | Nov 14, 2023 |
| Stephens | Ben Bienvenu | $70 | $47.58 | +35.1% | Nov 14, 2023 |
| Goldman Sachs | Adam Samuelson | $52 | $46.4 | +0.3% | Nov 10, 2023 |
| UBS | Kevin Caliendo | $37 | $52.66 | -28.6% | Jul 24, 2023 |
| Deutsche Bank | Steve Powers | $35 | $50.39 | -32.5% | May 19, 2023 |
| Bernstein | Alexia Howard | $48 | $48.95 | -7.4% | May 9, 2023 |
| J.P. Morgan | Analyst unavailable | $63 | $59.92 | +21.6% | Feb 7, 2023 |
| Credit Suisse | Analyst unavailable | $58 | $61.08 | +11.9% | Feb 7, 2023 |
| Goldman Sachs | Analyst unavailable | $66 | $61.08 | +27.4% | Feb 7, 2023 |
| Piper Sandler | Analyst unavailable | $65 | $65.75 | +25.4% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $58 | $67.33 | +11.9% | Nov 28, 2022 |
| J.P. Morgan | Analyst unavailable | $70 | $64.34 | +35.1% | Nov 15, 2022 |
| BMO Capital | Analyst unavailable | $75 | $64.83 | +44.7% | Nov 15, 2022 |
| Piper Sandler | Michael Lavery | $79 | $79.92 | +52.5% | Aug 9, 2022 |
| Piper Sandler | Michael Lavery | $85 | $92.84 | +64.0% | May 10, 2022 |
| Piper Sandler | Michael Lavery | $81 | $90.1 | +56.3% | May 3, 2022 |
| BMO Capital | Kenneth Zaslow | $99 | $87.14 | +91.0% | Mar 18, 2022 |
Track every rating change on TSN the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationTyson Foods, Inc. operates as a prominent global food producer, encompassing a broad range of activities across four core divisions: Beef, Pork, Chicken, and Prepared Foods. Within its Beef and Pork segments, the company manages the entire process from live cattle and hogs to their transformation into various meat products. This includes fabricating whole carcasses into primary and secondary cuts, providing case-ready options, and producing fully cooked meats. Its Chicken division is responsible for raising and processing poultry, delivering a spectrum of fresh, frozen, and value-added chicken items, and also supplying breeding stock. Additionally, Tyson markets specialty by-products such as animal hides. The Prepared Foods unit focuses on manufacturing and distributing a diverse portfolio of frozen and refrigerated convenience foods.…
Historical context
All TSN earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| KR The Kroger Co. | FY2026 Q2 · Calendar Q3 2026 | +2.8% | +2.7% | Kroger: Strong digital growth offsets softer sales outlook |
| CPB Campbell Soup Company | FY2026 Q4 · Calendar Q3 2026 | +1.1% | -7.0% | Campbell’s leans on savings and innovation amid pressured demand |
| BF-A Brown-Forman Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | — | Brown-Forman holds FY27 outlook as RTD innovation offsets barrel pressure |
| BF-B Brown-Forman Corporation | FY2027 Q1 · Calendar Q3 2026 | 0.0% | — | Brown-Forman maintains FY27 outlook as innovation offsets pressure |
| DG Dollar General Corporation | FY2027 Q2 · Calendar Q3 2026 | +23.4% | +2.5% | Dollar General Raises FY2026 Outlook After Strong Q2 |
| DLTR Dollar Tree, Inc. | FY2027 Q2 · Calendar Q3 2026 | +134.8% | -3.9% | Dollar Tree: Strong Q2 execution, but guidance held steady |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the TSN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-04T15:13:47.692611+00:00
- FN2 earnings calendar · 2026-09-08T01:23:13.784197+00:00
- Polygon adjusted daily market bars · 2026-09-23T04:40:50.514990+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T04:40:50.512058+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.